![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, February 19, 2020 8:23:37 AM
"...Musculoskeletal pain is a consequence of cumulative trauma, repetitive strain or overuse and refers to pain in the muscles, bones, ligaments, tendons, and nerves..." (From BIEL's statement)
The statement indicates BIEL has clearance for all nerve pain, which is either true or is poorly written (I'm not calling them liars, though incomplete information can be interpreted as being deceptive.). What type of nerve pain should be indicated (for instance peripheral versus autonomic). Dumbing this down is not helpful.If BIEL got clearance for all nerve pain, then allay and migraine are already approved, is my point. If not, which nervous system they have it for should be specified.
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM